[Form 4] PetMed Express, Inc. Insider Trading Activity
PetMed Express insider purchase reported. Silvercape Investments Ltd filed a Form 4 showing it acquired 101,000 shares of PETS at $3.17 on 08/13/2025, increasing its direct beneficial ownership to 2,579,696 shares. The filing lists the reporting relationship as Director, shows transaction code P (purchase), and is signed by Peter Kennedy on 08/14/2025.
Segnalato acquisto da insider di PetMed Express. Silvercape Investments Ltd ha presentato un Form 4 che mostra l'acquisto di 101.000 azioni di PETS a $3,17 il 08/13/2025, portando la sua partecipazione diretta come beneficiario a 2,579,696 azioni. La dichiarazione indica il ruolo come Direttore, riporta il codice di transazione P (acquisto) ed 猫 firmata da Peter Kennedy il 08/14/2025.
Reportada compra de insider de PetMed Express. Silvercape Investments Ltd present贸 un Form 4 que muestra la adquisici贸n de 101.000 acciones de PETS a $3,17 el 08/13/2025, aumentando su propiedad beneficiaria directa a 2,579,696 acciones. La presentaci贸n indica la relaci贸n informante como Director, muestra el c贸digo de transacci贸n P (compra) y est谩 firmada por Peter Kennedy el 08/14/2025.
PetMed Express 雮措秬鞛� 毵れ垬 氤搓碃. Silvercape Investments Ltd電� Form 4毳� 鞝滌稖頃橃棳 08/13/2025鞐� PETS 欤检嫕 101,000欤茧ゼ 欤茧嫻 $3.17鞐� 旆摑頃� 歆侅爲 鞁れ 氤挫湢欤检嫕鞚� 2,579,696欤茧 電橂牳鞀惦媹雼�. 鞁犼碃靹滌棎電� 氤搓碃鞛� 歆�鞙勲ゼ 鞚挫偓搿� 旮办灛頃橁碃 鞛堨溂氅�, 瓯半灅 旖旊摐電� P(毵れ垬)搿� 響滌嫓霅橃柎 鞛堦碃 08/14/2025鞐� Peter Kennedy臧� 靹滊獏頄堨姷雼堧嫟.
Achat d'initi茅 de PetMed Express signal茅. Silvercape Investments Ltd a d茅pos茅 un Form 4 indiquant qu'elle a acquis 101 000 actions de PETS 脿 3,17 $ le 08/13/2025, portant sa participation b茅n茅ficiaire directe 脿 2,579,696 actions. Le d茅p么t indique la relation d茅clar茅e comme Directeur, indique le code de transaction P (achat) et est sign茅 par Peter Kennedy le 08/14/2025.
Insider-Kauf von PetMed Express gemeldet. Silvercape Investments Ltd reichte ein Form 4 ein, das den Erwerb von 101.000 Aktien von PETS zu $3,17 am 08/13/2025 zeigt und damit sein direktes wirtschaftliches Eigentum auf 2,579,696 Aktien erh枚hte. Die Meldung nennt das meldende Verh盲ltnis als Direktor, weist den Transaktionscode P (Kauf) aus und ist am 08/14/2025 von Peter Kennedy unterzeichnet.
- Reported acquisition of 101,000 PETS shares at $3.17 on 08/13/2025
- Direct beneficial ownership increased to 2,579,696 shares following the purchase
- Form 4 includes required signature (Peter Kennedy, dated 08/14/2025)
- None.
Insights
TL;DR: Director-related entity purchased 101,000 PETS shares, modestly increasing direct ownership to 2.58M shares.
The Form 4 discloses a purchase (transaction code P) of 101,000 common shares at $3.17 per share on 08/13/2025, bringing direct beneficial ownership to 2,579,696 shares. This is a straightforward insider buy reported by Silvercape Investments Ltd with no derivative activity disclosed. The transaction is informative but, without context on company size or market value, its materiality to valuation is unclear from the filing alone.
TL;DR: Filing is complete for the disclosed non-derivative purchase and includes a manual signature.
The Form 4 includes required elements: reporting person name and address, issuer and ticker, transaction date (08/13/2025), transaction details (101,000 shares at $3.17), resulting beneficial ownership, and a signature dated 08/14/2025 by Peter Kennedy. No amendments or derivative transactions are shown. The report meets standard disclosure expectations for Section 16 filings.
Segnalato acquisto da insider di PetMed Express. Silvercape Investments Ltd ha presentato un Form 4 che mostra l'acquisto di 101.000 azioni di PETS a $3,17 il 08/13/2025, portando la sua partecipazione diretta come beneficiario a 2,579,696 azioni. La dichiarazione indica il ruolo come Direttore, riporta il codice di transazione P (acquisto) ed 猫 firmata da Peter Kennedy il 08/14/2025.
Reportada compra de insider de PetMed Express. Silvercape Investments Ltd present贸 un Form 4 que muestra la adquisici贸n de 101.000 acciones de PETS a $3,17 el 08/13/2025, aumentando su propiedad beneficiaria directa a 2,579,696 acciones. La presentaci贸n indica la relaci贸n informante como Director, muestra el c贸digo de transacci贸n P (compra) y est谩 firmada por Peter Kennedy el 08/14/2025.
PetMed Express 雮措秬鞛� 毵れ垬 氤搓碃. Silvercape Investments Ltd電� Form 4毳� 鞝滌稖頃橃棳 08/13/2025鞐� PETS 欤检嫕 101,000欤茧ゼ 欤茧嫻 $3.17鞐� 旆摑頃� 歆侅爲 鞁れ 氤挫湢欤检嫕鞚� 2,579,696欤茧 電橂牳鞀惦媹雼�. 鞁犼碃靹滌棎電� 氤搓碃鞛� 歆�鞙勲ゼ 鞚挫偓搿� 旮办灛頃橁碃 鞛堨溂氅�, 瓯半灅 旖旊摐電� P(毵れ垬)搿� 響滌嫓霅橃柎 鞛堦碃 08/14/2025鞐� Peter Kennedy臧� 靹滊獏頄堨姷雼堧嫟.
Achat d'initi茅 de PetMed Express signal茅. Silvercape Investments Ltd a d茅pos茅 un Form 4 indiquant qu'elle a acquis 101 000 actions de PETS 脿 3,17 $ le 08/13/2025, portant sa participation b茅n茅ficiaire directe 脿 2,579,696 actions. Le d茅p么t indique la relation d茅clar茅e comme Directeur, indique le code de transaction P (achat) et est sign茅 par Peter Kennedy le 08/14/2025.
Insider-Kauf von PetMed Express gemeldet. Silvercape Investments Ltd reichte ein Form 4 ein, das den Erwerb von 101.000 Aktien von PETS zu $3,17 am 08/13/2025 zeigt und damit sein direktes wirtschaftliches Eigentum auf 2,579,696 Aktien erh枚hte. Die Meldung nennt das meldende Verh盲ltnis als Direktor, weist den Transaktionscode P (Kauf) aus und ist am 08/14/2025 von Peter Kennedy unterzeichnet.
FAQ
What transaction did Silvercape Investments Ltd report for PETS?
How many PETS shares does Silvercape Investments Ltd beneficially own after the transaction?
What is the transaction code and what does it indicate?
Who signed the Form 4 for this filing?
Were any derivative securities reported in this Form 4 for PETS?
